The role of antibodies in respiratory viral immunity

Seminars in Virology

Volumn 7, Issue 4, 1996, Pages 273-283

  Crowe Jr , James E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Influenza virus; Parainfluenza virus; Passive immunization; Respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN A; INFLUENZA VACCINE; VIRUS ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; NONHUMAN; REINFECTION; RESPIRATORY TRACT INFECTION; VACCINE PRODUCTION; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALIA; INFLUENZA VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0030221043     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0034     Document Type: Article

References (100)

1. 1. Outlaw MC, Dimmock NJ (1990) Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J Gen Virol 71:69-76
2. 2. Armstrong SJ, Outlaw MC, Dimmock NJ (1990) Morphological studies of the neutralization of influenza virus by IgM. J Gen Virol 71:2313-2319
3. 3. Armstrong SJ, Dimmock NJ (1992) Neutralization of influenza virus by low concentrations of HA-specific polymeric IgA inhibits viral fusion activity but activation of the ribonucleo-protein is also inhibited. J Virol 66:3823-3832
4. 4. Markwell MA, Paulson JC (1980) Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci USA 77:5693-5697
5. 5. Coelingh KL, Winter CC, Murphy BR, et al (1986) Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies. J Virol 60:90-96
6. 6. Levine S, Klaiber-Franco R, Paradiso PR (1987) Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68:2521-2524
7. 7. Taylor HP, Dimmock NJ (1985) Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med 161:198-209
8. 8. Outlaw MC, Armstrong SJ, Dimmock NJ (1990) Mechanisms of neutralization of influenza virus in tracheal epithelial and BHK cells vary according to IgG concentration. Virology 178:478-485
9. 9. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378
10. 10. Osiowy C, Anderson R (1995) Neutralization of respiratory syncytial virus after cell attachment. J Virol 69:1271-1274
11. 11. Coelingh KLVW, Tierney EL (1989) Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein. J Virol 63:3755-3760
12. 12. Beeler JA, Coelingh KLVW (1989) Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function. J Virol 63:2941-2950
13. 13. Heminway BR, Yu Y, Tanaka Y, Perrine KG, Gustafson E, Bernstein JM, Galinski MS (1994) Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology 200:801-805
14. 14. Heminway BR, Yu Y, Galinski MS (1994) Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res 31:1-16
15. 15. Outlaw MC, Dimmock NJ (1993) IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells. Virology 195:413-421
16. 16. Sangster M, Hyland L, Sealy R, Coleclough C (1995) Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 207:287-291
17. 17. Johnson RA, Prince GA, Suffin SC, Horswood RL, Chanock RM (1982) Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect Immun 37:369-373
18. 18. Bender BS, Croghan T, Zhang L, Small PA Jr (1992) Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175:1143-1145
19. 19. Fouillard L, Mouthon L, Laporte JP, et al (1992) Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplant 9:97-100
20. 20. Harrington RD, Hooton TM, Hackman RC, et al (1992) An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 165:987-993
21. 21. Hall CB, Powell KR, MacDonald NE, et al (1986) Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 315:77-81
22. 22. Fishaut M, Tubergen D, McIntosh K (1980) Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 96:179-186
23. 23. Whimbey E, Vartivarian SE, Champlin RE, Elting LS, Luna M, Bodey GP (1993) Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 12:699-701
24. 24. Wendt CH, Weisdorf DJ, Jordan MC, Balfour HH Jr, Hertz MI (1992) Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326:921-926
25. + T cells. J Immunol 144:3980
26. 26. Doherty PC, Allan W, Eichelberger M, Carling SR (1992) Roles of alpha-beta and gamma-delta T cell subsets in viral immunity. Annu Rev Immunol 10:123-151
27. + T cells act as effector cells in protection against influenza virus infection? Immunology 62:139-144
28. 28. Cannon MJ, Openshaw PJ, Askonas BA (1988) Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 168:1163-1168
29. 29. Munoz JL, McCarthy CA, Clark ME, Hall CB (1991) Respiratory syncytial virus infection in C57BL/ 6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol 65:4494-4497
30. 30. Cannon MJ, Stott EJ, Taylor G, Askonas BA (1987) Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133-138
31. + cytotoxic T cells. Immunology 67:375-381
32. 32. Anderson JJ, Norden J, Saunders D, Toms GL, Scott R (1990) Analysis of the local and systemic immune responses induced in BALB/ c mice by experimental respiratory syncytial virus infection. J Gen Virol 71:1561-1570
33. + T cells. J Exp Med 174:875
34. + lymphocyte subsets. Microbiol Path 14:75-84
35. 35. Sarawar SR, Sangster M, Coffman RL, Doherty PC (1994) Administration of anti-interferon gamma to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol 153:1246-1253
36. 36. Scherle PA, Palladino G, Gerhard W (1992) Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 148:212
37. 37. Virelizier JL (1975) Host defenses against influenza virus: the role of antihemagglutinin antibody. J Immunol 115:434-439
38. 38. Palladino G, Mozdzanowska K, Washko G, Gerhard W (1995) Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotyp es can cure influenza virus pneumonia in SCID mice. J Virol 69:2075-2081
39. 39. Kris RM, Yetter RA, Cogliano R, Ramphal R, Small PA Jr (1988) Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea, and lung of nude mice. Immunology 63:349-353
40. 40. Schulman JL, Petrogrow C, Woodruff J (1977) Effects of cell mediated immunity in influenza infections in mice. Dev Biol Stand 39:385-390
41. 41. Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT (1991) Respiratory syncytial virus infection in anti-mu-treated mice. J Virol 65:4936-4942
42. 42. Kris RM, Asofsky R, Evans CB, Small PA (1985) Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol 134:1230-1234
43. 43. Murphy BR, Graham BS, Prince GA, et al (1986) Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Micronbiol 23:1009-1014
44. 44. Hornsleth A, Friis B, Grauballe PC, et al (1984) Detection by ELISA of IgA and IgM antibodies in secretion and IgM antibodies in serum in primary lower respiratory syncytial virus infection. J Med Virol 13:149-161
45. 45. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM (1978) The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 138:24-32
46. 46. Hemming VG, Rodriguez W, Kim HW, et al (1987) Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 31:1882-1886
47. 47. Parrott RH,Kim HW,Arrobio JO, et al (1973) Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 98:289-300
48. 48. Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S (1981) Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7:263-271
49. 49. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL (1981) Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98:708-715
50. 50. Glezen WP, Frank AL, Taber LH, Kasel JA (1984) Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 150:851-857
51. 51. Puck JM, Glezen WP, Frank AL, et al (1980) Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 142:844-849
52. 52. Walsh EE, Schlesinger JJ, Brandriss MW (1984) Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immunol 43:756-758
53. 53. Prince GA, Hemming VG, Horswood RL, Chanock RM (1985) Immunoprophylaxis and immunotherapyof respiratory syncytial virus infection in the cotton rat. Virus Res 3:193-206
54. 54. Taylor G, Stott EJ, Bew M, et al (1984) Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142
55. 55. Prince GA, Hemming VG, Horswood RL, Baron PA, Chanock RM (1987) Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol 61:1851-1854
56. 56. Groothius JR, Simoes EA, Levin MJ et al (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524-1530
57. 57. Prince GA, Horswood RL, Chanock RM (1985) Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol 55:517-520
58. 58. Crowe JE Jr, Murphy BR, Chanock RM, Williamson RA, Barbas CF III, Burton DR (1994) Recombinant human RSV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of respiratory syncytial virus-infected mice. Proc Natl Acad Sci USA 91:1386-1390
59. 59. Connors M, Collins PL, Firestone CY, Murphy BR (1991) Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 65:1634-1637
60. 60. Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR (1993) Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J Immunol 150:5484-5493
61. + T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. J Virol 66:1277-1281
62. 62. Welliver RC, Kaul TN, Putnam TI, Sun M, Riddlesberger K, Ogra PL (1980) The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr 96:808-813
63. 63. Murphy BR, Alling DW, Snyder MH, et al (1986) Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 24:894-898
64. 64. Murphy BR, Olmsted RA, Collins PL, Chanock PM, Prince GA (1988) Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J Virol 62:3907-3910
65. 65. Murphy BR, Collins PL, Lawrence L, Zubak J, Chanock RM, Prince GA (1989) Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV combinants. J Gen Virol 70:2185-2190
66. 66. Crowe JE Jr, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR (1995) Cold-passaged, temperature sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine 13:847-855
67. 67. Frank AL, Taber LH, Glezen WP, et al (1979) Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis 140;829-836
68. 68. Frank AL, Taber LH (1983) Variation in frequency of natural reinfection with influenza A viruses. J Med Virol 12:17-23
69. 69. Wagner DK, Muelenaer P, Henderson FW, et al (1989) Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections. J Clin Microbiol 27:589-592
70. 70. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL (1981) Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child 135:1013-1016
71. 71. Wright PF, Murphy BR, Kervina M, Lawrence EM, Phelan MA, Karzon DT (1983) Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun 40:1092-1095
72. 72. Mazanec MB, Nedrud JG, Liang XP, Lamm ME (1989) Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. J Immunol 142:4275-4281
73. 73. Hemming VG, Prince GA, London WT, Baron PA, Brown R, Chanock RM (1988) Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys. Antimicrob Agents Chemother 32:1269-1270
74. 74. Mazanec MB, Lamm ME, Lyn D, Portner A, Nedrud JG (1992) Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res 23:1-12
75. 75. Mazanec MB, Kzetzel CS, Lamm ME, Fletcher D, Nedrud JG (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89:6901-6905
76. 76. Renegar KB, Small PA Jr (1991) Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 65:2146-2148
77. 77. Waldman RH, Gadal N, Olsen GN, et al (1973) Respiratory tract cell-mediated immunity to influenza infection. Symp Ser Immunobiol Stand 20:222-231
78. 78. Mills J, Van Kirk JE, Wright PF, Chanock RM (1971) Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol 107:123-130
79. 79. Watt PJ, Robinson BS, Pringle CR, Tyrrell DA (1990) Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines. Vaccine 8:231-236
80. 80. Smith CB, Purcell RH, Bellanti JA, Chanock RM (1966) Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med 275:1145-1152
81. 81. Yanagihara R, McIntosh K (1980) Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun 30:23-28
82. 82. Hall CB, Walsh EE, Long CE, Schnabel KC (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698
83. 83. Weltzin R, Hsu SA, Mittler ES, Georgakopoulos K, Monath TP (1994) Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob Agents Chemother 38:2785-2791
84. 84. Taylor G, Furze J, Tempest PR, Bremner P, Carr FJ, Harris WJ (1991) Humanised monoclonal antibody to respiratory syncytial virus [letter]. Lancet 337:1411-1412
85. 85. Tempest PR, Bremner P, Lambert M, et al(1991) Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vitro. Biotechnology (NY) 9:266-271
86. 86. Crowe JE Jr, Cheung PYK, Wallace E, et al (1994) Isolation and characterization of a chimpanzee monoclonal antibody to the G-glycoprotein of respiratory syncytial virus. Clin Diagn Lab Immunol 1:701-706
87. 87. Barbas CF III, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88:7978-7982
88. 88. Burton DR, Barbas CF III, Persson MAA, Koenig S, Chanock RM, Lerner RA (1991) A large array of human monoclonal antibodies to type I human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 88:10134-10137
89. 89. Clackson T, Hoogenboom HR, Griffiths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352:624-628
90. 90. Bender E, Pilkington GR, Burton DR (1994) Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus. Hum Antibod Hybrid 5:3-8
91. 91. Zebedee SL, Barbas CF III, Hom Y-L, et al (1992) Human combinatorial antibodies to hepatitis B surface antigen. Proc Natl Acad Sci USA 89:3175-3179
92. 92. Williamson RA, Burioni R, Sanna PP, Patridge LJ, Barbas CF, Burton DR (1993) Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci USA 90:4141-4145
93. 93. Barbas CF, Crowe JE Jr, Cababa D, et al (1992) Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci USA 89:10164-10168
94. 94. Crowe JE Jr, Barbas CF III, Bui PT, et al (1993) Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity, in Vaccines 93: Modern Approaches to New Vaccines Including Prevention of AIDS (Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds) pp 7-11. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
95. 95. Bender E, Woof JM, Atkin JD, Barker MD, Bebbington CR, Burton DR (1993) Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. Hum Antibod Hybrid 4:74-79
96. 96. Kang AS, Jones TM, Burton DR (1991) Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries. Proc Natl Acad Sci USA 88:11120-11123
97. 97. Collet TA, Roben P, O'Kennedy R, Barbas CF III, Burton DR, Lerner RA (1992) A binary plasmid system for shuffling combinatorial antibody libraries. Proc Natl Acad Sci USA 89:10026-10030
98. 98. Barbas CF III, Hu D, Dunlop N, et al (1994) Evolution of a neutralizing human antibody to human immunodeficiency virus type I to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci USA 91:3809-3813
99. 99. Ditzel HJ, Binley JM, Moore JP, et al (1995) Neutralizing recombinant human antibodies to a conformational V2-and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J Immunol 154:893-906
100. 100. Sanna PP, Williamson RA, De Logu A, Bloom FE, Burton DR (1995) Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci USA 92:6439-6444